HOME >> MEDICINE >> NEWS
Sandia nanolaser may help extend life-spans by rapidly analyzing possible neuroprotectant drugs

ALBUQUERQUE, NM. - Anyone visiting a nursing home has seen the horror of humans surviving beyond their brains' ability to make sense of their surroundings.

That loss of discrimination is caused by neurons killed by malfunctions in mitochondria - the submicron-sized power packs found in every animal cell.

These malfunctions are the most immediate cause of afflictions like Parkinson's, Huntington's, and Alzheimer's diseases.

Malfunctioning mitochondria have also been linked to battlefield aftereffects caused by radiation or by nerve agents like sarin.

But because mitochondria are so small, averaging a few hundred nanometers, scientists have been unable to study them in vitro with the necessary precision to determine the best possible neuroprotectants.

Now a unique laser operating in the nanometer range at the Department of Energy's Sandia National Laboratories has demonstrated the first-ever technique for studying the reactions of such ultrasmall biological organelles in their functioning state. The laser, using samples obtained from the University of New Mexico School of Medicine, has shown it can obtain clear signals from individual mitochondria in vitro.

Waterproofing mitochondria

"'Waterproofing' the mitochondria with specific protectant drugs would increase the survival chances of the brain," says Marcus Keep, a neurosurgeon professor at the University of New Mexico School of Medicine.

"Our goal is make the brain less susceptible to diseases like Lou Gehrig's," says Sandia researcher Paul Gourley, a physicist who grew up in a family of doctors.

Work to date has shown the biolaser (which recently won first place in the DOE's annual Basic Energy Sciences' competition for using light to quantify characteristics of anthrax spores) is able to measure mitochondrial size through unexpected bursts of light given up by each mitochondrion. The laser, using the same means, can also measure the s
'"/>

Contact: Neal Singer
nsinger@sandia.gov
505-845-7078
DOE/Sandia National Laboratories
23-Sep-2003


Page: 1 2 3 4 5

Related medicine news :

1. Sandia-developed foam likely would stop SARS virus quickly, Sandia/Kansas State team shows
2. Sandia helps public health officials with anti-terror decision analysis tool
3. Team studies use of Sandia technology to ensure farm-to-fork safety of the nations food supply
4. Not Cartier, but non-allergenic and long-lasting: Worlds first diamond micromachines created at Sandia
5. Global study shows new breast cancer drug extends patients overall survival
6. Deadline for the $10,000 Maxwell A. Pollack Award has been extended
7. Concern for European public health as EU border extends to the east
8. Post-traumatic stress disorder increases in children with extended ICU stays after cardiac surgery
9. GP training should be extended
10. Report 13 in RERF study of mortality of A-bomb survivors extends coverage through 1997
11. New brain cancer treatment extends survival for more patients

Post Your Comments:
(Date:5/22/2013)... WEDNESDAY, May 22 (HealthDay News) -- Fish oil ... 2 diabetes, new research suggests. The ... levels of a hormone called adiponectin that,s linked ... of this hormone in the bloodstream have also ... disease. "While prior animal studies found fish ...
(Date:5/22/2013)... at Massachusetts General Hospital (MGH) one of the ... half rated the training they had received in addiction ... Significant numbers felt unprepared to diagnose or treat such ... response to the findings, recently published online in the ... residents, training in addiction medicine. , "Our residents ...
(Date:5/22/2013)... effect does a father,s depression have on his young son ... intimacy in their marriage, their children benefit, said a University ... their child, they need to be able to attend to ... stage and abilities, and notice whether he is getting frustrated ... said Nancy McElwain, a U of I professor of human ...
(Date:5/22/2013)... A new study suggests that disturbed sleep in ... and greater uncertainly about future success. However, ... appears to have a protective effect. , ... with depressed mood and greater uncertainty about future ... and from teachers were associated with significantly fewer ...
(Date:5/22/2013)... "power plants" that make energy to keep cells alive ... of the drug-resistant forms of cancer source of ... conclusion of a new study published in the journal ... and colleagues explain that doxorubicin and other common forms ... nucleus of cancer cells. Cancer cells divide and multiply ...
Breaking Medicine News(10 mins):Health News:Fish Oil Pills Might Cut Diabetes Risk, Researchers Say 2Health News:Survey points out deficiencies in addictions training for medical residents 2Health News:Survey points out deficiencies in addictions training for medical residents 3Health News:Survey points out deficiencies in addictions training for medical residents 4Health News:Good marriage can buffer effects of dad's depression on young children 2Health News:Parent and teacher support protects teens from sleep problems and depression 2
(Date:5/22/2013)... , May 22, 2013 Ranbaxy Laboratories ... Co., Ltd. (hereafter, Daiichi Sankyo), announced on May ... recent years to address past conduct under prior ... Daiichi Sankyo continues to support Ranbaxy ... conduct of the past which led to the ...
(Date:5/22/2013)... 22. Mai 2013  Grifols, ein globales ... Barcelona , Spanien, präsentierte die ... höhere Dosis von PROLASTIN©-C (Alpha1-Proteinasehemmer [human]) den ... (AAT) auf ein Niveau anhebt, das innerhalb ... liegt. ATT-Mangel ist eine lebensbedrohliche, genetische Erkrankung, ...
(Date:5/22/2013)... and REHOVOT, Israel , May 22, ... ), a leading developer and provider of microRNA-based molecular ... , President and Chief Executive Officer of Rosetta Genomics, ... Healthcare Conference taking place from June 3-6, 2013 in ... on Tuesday, June 4 th at 2:00 p.m. ...
Breaking Medicine Technology:Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 2Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 3Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 4Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 2Rosetta Genomics to Present at the Jefferies 2013 Healthcare Conference 3
Cached News: